TNF and metabolic syndrome: In T2DM, low grade inflammation may also contribute to dyslipidemia as Tumor Necrosis Factor-α (TNF-α) is associated with an increase of intestinal lipoprotein secretion that may elevate chylomicron production in an insulin resistant state [8,9].